Menu
Recruiting NCT07061522

Effects of Smoking Addiction on Lower Limb Speed and Coordination

Observational Smoking Cessation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Behavioral/Physical Assessment.
Who it may be relevant to
Registry conditions: Smoking Cessation. Basic parameters: 18 years — 25 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Investigation of the Impact of Smoking Addiction on the Speed and Coordination of Lower Extremity Movements

Overview

This observational case-control study will investigate the impact of smoking addiction on lower extremity speed and coordination in young adults. Participants aged 18-25 will be divided into two groups based on their smoking status. The study will compare motor coordination and sprint performance between smokers and non-smokers using objective physical tests under standardized laboratory conditions.

Detailed description

This non-randomized controlled study will aim to evaluate the effects of smoking addiction on the speed and coordination of lower extremity movements among healthy young adults. Smoking is known to have detrimental effects on vascular, musculoskeletal, and neurological systems, yet its impact on motor performance-particularly in the lower limbs-has not been sufficiently studied.

Participants aged 18-25 will be categorized into smoker and non-smoker groups based on DSM-IV-TR nicotine dependence criteria and the Fagerström Test. The Lower Extremity Motor Coordination Test (LEMOCOT) will be used to assess motor coordination, while a 30-meter sprint test will evaluate movement speed. Additionally, body mass index (BMI) and bimalleolar diameter and circumference will be recorded to control for confounding physical variables.

All assessments will be conducted in a controlled laboratory environment. The results will be analyzed to determine whether smoking addiction is associated with impaired lower limb motor function. The findings may provide new insights into the functional consequences of smoking in young adults and contribute to the design of preventive and rehabilitative strategies.

Interventions

  • Other Behavioral/Physical Assessment
    This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lo

Primary outcome measures

  • Lower Extremity Coordination Score [Time frame: Baseline]
  • Sprint Time [Time frame: Baseline]
Secondary outcome measures (3)
  • Nicotine Dependence Score [Time frame: Baseline]
  • BMI (Body Mass Index) [Time frame: Baseline]
  • Bimalleolar Diameter and Circumference [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Smoking ≥1 cigarette daily for at least 12 months
  • Age between 18-25
  • Literate and cooperative
  • BMI: 18.5-29.9 kg/m²

Exclusion criteria

  • Orthopedic, neurological, or neuromuscular conditions impairing walking
  • Chronic pulmonary or cardiac disease
  • Cognitive impairment
  • BMI ≥30 kg/m²

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Esra Pehlivan — Istanbul

Identifiers

NCT: NCT07061522 · Smoking Add-Coordination-1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗